Structure

Physi-Chem Properties

Molecular Weight:  1595.55
Volume:  1444.55
LogP:  3.897
LogD:  2.664
LogS:  -3.739
# Rotatable Bonds:  23
TPSA:  479.1
# H-Bond Aceptor:  39
# H-Bond Donor:  8
# Rings:  13
# Heavy Atoms:  40

MedChem Properties

QED Drug-Likeness Score:  0.048
Synthetic Accessibility Score:  8.272
Fsp3:  0.8
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.021
MDCK Permeability:  0.000792263715993613
Pgp-inhibitor:  0.002
Pgp-substrate:  1.0
Human Intestinal Absorption (HIA):  0.641
20% Bioavailability (F20%):  0.0
30% Bioavailability (F30%):  0.06

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.239
Plasma Protein Binding (PPB):  66.052978515625%
Volume Distribution (VD):  -0.291
Pgp-substrate:  5.370580673217773%

ADMET: Metabolism

CYP1A2-inhibitor:  0.0
CYP1A2-substrate:  0.999
CYP2C19-inhibitor:  0.011
CYP2C19-substrate:  0.065
CYP2C9-inhibitor:  0.022
CYP2C9-substrate:  0.0
CYP2D6-inhibitor:  0.0
CYP2D6-substrate:  0.039
CYP3A4-inhibitor:  0.152
CYP3A4-substrate:  0.889

ADMET: Excretion

Clearance (CL):  0.253
Half-life (T1/2):  0.395

ADMET: Toxicity

hERG Blockers:  0.617
Human Hepatotoxicity (H-HT):  0.166
Drug-inuced Liver Injury (DILI):  0.996
AMES Toxicity:  0.133
Rat Oral Acute Toxicity:  0.065
Maximum Recommended Daily Dose:  0.02
Skin Sensitization:  0.793
Carcinogencity:  0.118
Eye Corrosion:  0.003
Eye Irritation:  0.027
Respiratory Toxicity:  0.035

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC85735

Natural Product ID:  NPC85735
Common Name*:   [(2R,3R,4R,6S)-6-[(2R,2'r,3's,3Ar,4R,4'r,6S,7S,7Ar)-6-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4S,5S,6S)-6-[(3Ar,3'as,4R,6's,7R,7'r,7As,7'as)-7-(2,4-Dihydroxy-6-Methylbenzoyl)Oxy-7'-Hydroxyspiro[3A,6,7,7A-Tetrahydro-[1,3]Dioxolo[4,5-C]Pyran-4,2'-4,6,7,7A-Tetrahydro-3Ah-[1,3]Dioxolo[4,5-C]Pyran]-6'-Yl]Oxy-4-Hydroxy-5-Methoxy-2-(Methoxymethyl)Oxan-3-Yl]Oxy-3-Hydroxy-5-Methoxy-6-Methyloxan-4-Yl]Oxy-4',7-Dihydroxy-2',4,7A-Trimethylspiro[3A,4,6,7-Tetrahydro-[1,3]Dioxolo[4,5-C]Pyran-2,6'-Oxane]-3'-Yl]Oxy-4-[(2S,4S,5R,6S)-5-Methoxy-4,6-Dimethyl-4-Nitrooxan-2-Yl]Oxy-2-Methyloxan-3-Yl] 3-Chloro-4-Hydroxy-2-Methoxy-6-Methylbenzoate
IUPAC Name:   [(2R,3R,4R,6S)-6-[(2R,2'R,3'S,3aR,4R,4'R,6S,7S,7aR)-6-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4S,5S,6S)-6-[(3aR,3'aS,4R,6'S,7R,7'R,7aS,7'aS)-7-(2,4-dihydroxy-6-methylbenzoyl)oxy-7'-hydroxyspiro[3a,6,7,7a-tetrahydro-[1,3]dioxolo[4,5-c]pyran-4,2'-4,6,7,7a-tetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran]-6'-yl]oxy-4-hydroxy-5-methoxy-2-(methoxymethyl)oxan-3-yl]oxy-3-hydroxy-5-methoxy-6-methyloxan-4-yl]oxy-4',7-dihydroxy-2',4,7a-trimethylspiro[3a,4,6,7-tetrahydro-[1,3]dioxolo[4,5-c]pyran-2,6'-oxane]-3'-yl]oxy-4-[(2S,4S,5R,6S)-5-methoxy-4,6-dimethyl-4-nitrooxan-2-yl]oxy-2-methyloxan-3-yl] 3-chloro-4-hydroxy-2-methoxy-6-methylbenzoate
Synonyms:   SCH-58771
Standard InCHIKey:  FLUSUFZXDQYQHR-ZHWARYNPSA-N
Standard InCHI:  InChI=1S/C70H98ClNO38/c1-25-15-32(73)17-33(74)42(25)61(81)99-38-23-93-70(60-53(38)91-24-92-60)107-39-22-90-63(46(78)52(39)108-70)105-65-56(88-13)45(77)51(37(100-65)21-85-10)103-64-47(79)55(50(86-11)28(4)96-64)104-66-57(80)68(9)59(31(7)97-66)109-69(110-68)19-35(76)48(29(5)106-69)101-40-18-36(98-41-20-67(8,72(83)84)58(89-14)30(6)95-41)49(27(3)94-40)102-62(82)43-26(2)16-34(75)44(71)54(43)87-12/h15-17,27-31,35-41,45-53,55-60,63-66,73-80H,18-24H2,1-14H3/t27-,28-,29-,30+,31-,35-,36-,37-,38-,39+,40+,41+,45+,46-,47-,48-,49-,50+,51-,52-,53+,55-,56+,57-,58+,59-,60-,63+,64+,65+,66+,67+,68-,69-,70-/m1/s1
SMILES:  COC[C@H]1O[C@@H](O[C@@H]2OC[C@H]3[C@H]([C@H]2O)O[C@@]2(O3)OC[C@H]([C@H]3[C@H]2OCO3)OC(=O)c2c(C)cc(cc2O)O)[C@H]([C@H]([C@@H]1O[C@@H]1O[C@H](C)[C@@H]([C@@H]([C@H]1O)O[C@@H]1O[C@H](C)[C@@H]2[C@]([C@@H]1O)(C)O[C@]1(O2)C[C@@H](O)[C@@H]([C@H](O1)C)O[C@@H]1O[C@H](C)[C@H]([C@@H](C1)O[C@@H]1O[C@@H](C)[C@@H]([C@@](C1)(C)N(=O)=O)OC)OC(=O)c1c(C)cc(c(c1OC)Cl)O)OC)O)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL447387
PubChem CID:   44575974
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0000011] Carbohydrates and carbohydrate conjugates
          • [CHEMONTID:0000198] Oligosaccharides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO21710.1 Micromonospora carbonacea Under-species n.a. n.a. n.a. n.a. n.a. PMID[12444681]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT16 Organism Staphylococcus aureus Staphylococcus aureus IZ = 17.0 mm PMID[501779]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus IZ = 16.0 mm PMID[501779]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus IZ = 20.0 mm PMID[501779]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC85735 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9747 High Similarity NPC133678
0.961 High Similarity NPC83933
0.9515 High Similarity NPC167027
0.774 Intermediate Similarity NPC136411
0.7677 Intermediate Similarity NPC69868
0.7574 Intermediate Similarity NPC249977
0.7525 Intermediate Similarity NPC257309
0.7475 Intermediate Similarity NPC7752
0.7475 Intermediate Similarity NPC99216
0.7463 Intermediate Similarity NPC137871
0.7463 Intermediate Similarity NPC9002
0.7463 Intermediate Similarity NPC257011
0.7463 Intermediate Similarity NPC288152
0.7438 Intermediate Similarity NPC68592
0.7438 Intermediate Similarity NPC298666
0.7438 Intermediate Similarity NPC262222
0.7415 Intermediate Similarity NPC199079
0.7415 Intermediate Similarity NPC210808
0.7404 Intermediate Similarity NPC120952
0.7404 Intermediate Similarity NPC241196
0.7395 Intermediate Similarity NPC470194
0.7395 Intermediate Similarity NPC470198
0.7395 Intermediate Similarity NPC470195
0.7395 Intermediate Similarity NPC470197
0.7395 Intermediate Similarity NPC470200
0.7395 Intermediate Similarity NPC316274
0.7395 Intermediate Similarity NPC282474
0.7395 Intermediate Similarity NPC470196
0.7395 Intermediate Similarity NPC314687
0.7395 Intermediate Similarity NPC470193
0.7391 Intermediate Similarity NPC63105
0.7371 Intermediate Similarity NPC470099
0.7359 Intermediate Similarity NPC316461
0.734 Intermediate Similarity NPC311850
0.7333 Intermediate Similarity NPC470453
0.7333 Intermediate Similarity NPC164047
0.7333 Intermediate Similarity NPC470448
0.7333 Intermediate Similarity NPC469371
0.7333 Intermediate Similarity NPC470452
0.7321 Intermediate Similarity NPC471802
0.7311 Intermediate Similarity NPC221140
0.7311 Intermediate Similarity NPC229817
0.7311 Intermediate Similarity NPC475220
0.7311 Intermediate Similarity NPC475352
0.7311 Intermediate Similarity NPC473686
0.7308 Intermediate Similarity NPC198199
0.7302 Intermediate Similarity NPC470199
0.7302 Intermediate Similarity NPC314459
0.7299 Intermediate Similarity NPC35924
0.7299 Intermediate Similarity NPC199172
0.7291 Intermediate Similarity NPC475382
0.7291 Intermediate Similarity NPC298171
0.729 Intermediate Similarity NPC470100
0.7286 Intermediate Similarity NPC84494
0.7286 Intermediate Similarity NPC245059
0.7281 Intermediate Similarity NPC313541
0.7277 Intermediate Similarity NPC328093
0.7277 Intermediate Similarity NPC282636
0.7277 Intermediate Similarity NPC294863
0.7268 Intermediate Similarity NPC70441
0.726 Intermediate Similarity NPC213052
0.7255 Intermediate Similarity NPC473644
0.7251 Intermediate Similarity NPC475161
0.7251 Intermediate Similarity NPC477860
0.7246 Intermediate Similarity NPC138990
0.7246 Intermediate Similarity NPC175429
0.7246 Intermediate Similarity NPC209550
0.7246 Intermediate Similarity NPC298778
0.7246 Intermediate Similarity NPC277532
0.7241 Intermediate Similarity NPC101636
0.7235 Intermediate Similarity NPC48822
0.723 Intermediate Similarity NPC33083
0.723 Intermediate Similarity NPC241847
0.7228 Intermediate Similarity NPC279732
0.722 Intermediate Similarity NPC287889
0.722 Intermediate Similarity NPC135358
0.7217 Intermediate Similarity NPC473631
0.7217 Intermediate Similarity NPC473717
0.7217 Intermediate Similarity NPC475662
0.7217 Intermediate Similarity NPC293227
0.7212 Intermediate Similarity NPC470560
0.7212 Intermediate Similarity NPC180918
0.7212 Intermediate Similarity NPC261254
0.7204 Intermediate Similarity NPC192539
0.7198 Intermediate Similarity NPC293629
0.7198 Intermediate Similarity NPC473202
0.7198 Intermediate Similarity NPC105283
0.7198 Intermediate Similarity NPC43587
0.7192 Intermediate Similarity NPC246469
0.7192 Intermediate Similarity NPC97285
0.7192 Intermediate Similarity NPC142860
0.7192 Intermediate Similarity NPC271270
0.719 Intermediate Similarity NPC255799
0.719 Intermediate Similarity NPC292019
0.719 Intermediate Similarity NPC48984
0.719 Intermediate Similarity NPC312630
0.719 Intermediate Similarity NPC473862
0.719 Intermediate Similarity NPC122467
0.719 Intermediate Similarity NPC89127
0.719 Intermediate Similarity NPC324220
0.719 Intermediate Similarity NPC475233
0.719 Intermediate Similarity NPC46958
0.719 Intermediate Similarity NPC471669
0.719 Intermediate Similarity NPC202908
0.719 Intermediate Similarity NPC14187
0.7184 Intermediate Similarity NPC189564
0.7184 Intermediate Similarity NPC12013
0.7184 Intermediate Similarity NPC256188
0.7184 Intermediate Similarity NPC64425
0.7184 Intermediate Similarity NPC11432
0.7184 Intermediate Similarity NPC32641
0.7184 Intermediate Similarity NPC186816
0.7184 Intermediate Similarity NPC142142
0.7184 Intermediate Similarity NPC477613
0.7184 Intermediate Similarity NPC203145
0.7184 Intermediate Similarity NPC221342
0.7184 Intermediate Similarity NPC476470
0.7183 Intermediate Similarity NPC275977
0.7183 Intermediate Similarity NPC249560
0.7183 Intermediate Similarity NPC106700
0.7183 Intermediate Similarity NPC223860
0.7177 Intermediate Similarity NPC25724
0.7176 Intermediate Similarity NPC264302
0.7176 Intermediate Similarity NPC48474
0.7163 Intermediate Similarity NPC477572
0.7163 Intermediate Similarity NPC470562
0.7163 Intermediate Similarity NPC105095
0.7163 Intermediate Similarity NPC79056
0.7163 Intermediate Similarity NPC477571
0.7163 Intermediate Similarity NPC477573
0.7163 Intermediate Similarity NPC44328
0.7163 Intermediate Similarity NPC177731
0.7163 Intermediate Similarity NPC316091
0.7163 Intermediate Similarity NPC313386
0.7156 Intermediate Similarity NPC173837
0.7156 Intermediate Similarity NPC251417
0.7156 Intermediate Similarity NPC89052
0.715 Intermediate Similarity NPC473554
0.715 Intermediate Similarity NPC298847
0.715 Intermediate Similarity NPC295625
0.715 Intermediate Similarity NPC87583
0.715 Intermediate Similarity NPC470719
0.7143 Intermediate Similarity NPC470454
0.7143 Intermediate Similarity NPC199533
0.7143 Intermediate Similarity NPC473634
0.7143 Intermediate Similarity NPC68381
0.7143 Intermediate Similarity NPC102028
0.7143 Intermediate Similarity NPC22062
0.7143 Intermediate Similarity NPC138811
0.7143 Intermediate Similarity NPC474345
0.7136 Intermediate Similarity NPC241781
0.7136 Intermediate Similarity NPC162394
0.7136 Intermediate Similarity NPC156785
0.7136 Intermediate Similarity NPC475979
0.7136 Intermediate Similarity NPC15358
0.7136 Intermediate Similarity NPC131405
0.7136 Intermediate Similarity NPC292929
0.7136 Intermediate Similarity NPC76831
0.7136 Intermediate Similarity NPC289667
0.7136 Intermediate Similarity NPC72016
0.713 Intermediate Similarity NPC93065
0.713 Intermediate Similarity NPC39409
0.713 Intermediate Similarity NPC160543
0.713 Intermediate Similarity NPC472720
0.713 Intermediate Similarity NPC31208
0.713 Intermediate Similarity NPC187632
0.713 Intermediate Similarity NPC469652
0.713 Intermediate Similarity NPC472724
0.713 Intermediate Similarity NPC472721
0.7129 Intermediate Similarity NPC38438
0.7129 Intermediate Similarity NPC470715
0.7129 Intermediate Similarity NPC261866
0.7129 Intermediate Similarity NPC470714
0.7129 Intermediate Similarity NPC474522
0.7129 Intermediate Similarity NPC470716
0.7124 Intermediate Similarity NPC315253
0.7123 Intermediate Similarity NPC473895
0.7122 Intermediate Similarity NPC190450
0.7122 Intermediate Similarity NPC244875
0.7116 Intermediate Similarity NPC475360
0.7116 Intermediate Similarity NPC65489
0.7116 Intermediate Similarity NPC72554
0.7116 Intermediate Similarity NPC30011
0.7116 Intermediate Similarity NPC97817
0.7115 Intermediate Similarity NPC86008
0.7115 Intermediate Similarity NPC227508
0.7115 Intermediate Similarity NPC195257
0.7115 Intermediate Similarity NPC209296
0.7115 Intermediate Similarity NPC259905
0.7114 Intermediate Similarity NPC185103
0.711 Intermediate Similarity NPC247104
0.7109 Intermediate Similarity NPC475246
0.7109 Intermediate Similarity NPC472723
0.7109 Intermediate Similarity NPC231787
0.7109 Intermediate Similarity NPC219043
0.7108 Intermediate Similarity NPC200708
0.7108 Intermediate Similarity NPC473623
0.7108 Intermediate Similarity NPC470358
0.7104 Intermediate Similarity NPC108744
0.7103 Intermediate Similarity NPC25946

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC85735 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7342 Intermediate Similarity NPD7783 Phase 2
0.7342 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7175 Intermediate Similarity NPD8151 Discontinued
0.7163 Intermediate Similarity NPD7472 Approved
0.7163 Intermediate Similarity NPD7074 Phase 3
0.7143 Intermediate Similarity NPD7808 Phase 3
0.7115 Intermediate Similarity NPD7054 Approved
0.7104 Intermediate Similarity NPD7696 Phase 3
0.7104 Intermediate Similarity NPD7697 Approved
0.7104 Intermediate Similarity NPD7698 Approved
0.7095 Intermediate Similarity NPD7251 Discontinued
0.7072 Intermediate Similarity NPD8320 Phase 1
0.7072 Intermediate Similarity NPD8319 Approved
0.7054 Intermediate Similarity NPD7701 Phase 2
0.7048 Intermediate Similarity NPD6797 Phase 2
0.7033 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7018 Intermediate Similarity NPD7930 Approved
0.7 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.6996 Remote Similarity NPD7870 Phase 2
0.6996 Remote Similarity NPD7871 Phase 2
0.6991 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6991 Remote Similarity NPD7874 Approved
0.6986 Remote Similarity NPD7228 Approved
0.6968 Remote Similarity NPD6777 Approved
0.6968 Remote Similarity NPD6778 Approved
0.6968 Remote Similarity NPD6782 Approved
0.6968 Remote Similarity NPD6776 Approved
0.6968 Remote Similarity NPD6780 Approved
0.6968 Remote Similarity NPD6779 Approved
0.6968 Remote Similarity NPD6781 Approved
0.6959 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6927 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6878 Remote Similarity NPD7700 Phase 2
0.6878 Remote Similarity NPD7699 Phase 2
0.6875 Remote Similarity NPD7435 Discontinued
0.683 Remote Similarity NPD6823 Phase 2
0.6825 Remote Similarity NPD3818 Discontinued
0.6822 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6812 Remote Similarity NPD7801 Approved
0.6791 Remote Similarity NPD8312 Approved
0.6791 Remote Similarity NPD8313 Approved
0.6776 Remote Similarity NPD7240 Approved
0.6776 Remote Similarity NPD6559 Discontinued
0.6742 Remote Similarity NPD6535 Approved
0.6742 Remote Similarity NPD6534 Approved
0.6699 Remote Similarity NPD7819 Suspended
0.6695 Remote Similarity NPD8155 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7999 Approved
0.6651 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6651 Remote Similarity NPD6166 Phase 2
0.6651 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6651 Remote Similarity NPD6234 Discontinued
0.6635 Remote Similarity NPD4965 Approved
0.6635 Remote Similarity NPD4967 Phase 2
0.6635 Remote Similarity NPD4966 Approved
0.6634 Remote Similarity NPD4380 Phase 2
0.6608 Remote Similarity NPD5005 Approved
0.6608 Remote Similarity NPD5006 Approved
0.6603 Remote Similarity NPD7075 Discontinued
0.6592 Remote Similarity NPD4363 Phase 3
0.6592 Remote Similarity NPD4360 Phase 2
0.6588 Remote Similarity NPD6959 Discontinued
0.6574 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6573 Remote Similarity NPD2403 Approved
0.6557 Remote Similarity NPD5710 Approved
0.6557 Remote Similarity NPD5711 Approved
0.6555 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6544 Remote Similarity NPD7685 Pre-registration
0.6537 Remote Similarity NPD7585 Approved
0.6509 Remote Similarity NPD7199 Phase 2
0.6507 Remote Similarity NPD7680 Approved
0.65 Remote Similarity NPD970 Clinical (unspecified phase)
0.65 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6494 Remote Similarity NPD7583 Approved
0.6494 Remote Similarity NPD7584 Approved
0.649 Remote Similarity NPD37 Approved
0.649 Remote Similarity NPD1934 Approved
0.6489 Remote Similarity NPD4362 Clinical (unspecified phase)
0.6489 Remote Similarity NPD4361 Phase 2
0.6488 Remote Similarity NPD8058 Clinical (unspecified phase)
0.6488 Remote Similarity NPD8059 Phase 3
0.6479 Remote Similarity NPD6232 Discontinued
0.6473 Remote Similarity NPD6212 Phase 3
0.6473 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6473 Remote Similarity NPD6213 Phase 3
0.6471 Remote Similarity NPD8150 Discontinued
0.6471 Remote Similarity NPD2534 Approved
0.6471 Remote Similarity NPD2533 Approved
0.6471 Remote Similarity NPD2532 Approved
0.6465 Remote Similarity NPD7473 Discontinued
0.6459 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6459 Remote Similarity NPD8455 Phase 2
0.6459 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6432 Remote Similarity NPD4420 Approved
0.6429 Remote Similarity NPD3817 Phase 2
0.6429 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6413 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6406 Remote Similarity NPD5844 Phase 1
0.64 Remote Similarity NPD1852 Discontinued
0.6381 Remote Similarity NPD1465 Phase 2
0.6372 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6368 Remote Similarity NPD3749 Approved
0.6359 Remote Similarity NPD3751 Discontinued
0.6351 Remote Similarity NPD5402 Approved
0.6343 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6333 Remote Similarity NPD6801 Discontinued
0.6332 Remote Similarity NPD8285 Discontinued
0.6326 Remote Similarity NPD3787 Discontinued
0.6321 Remote Similarity NPD3882 Suspended
0.6309 Remote Similarity NPD7211 Clinical (unspecified phase)
0.6308 Remote Similarity NPD5494 Approved
0.6306 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6303 Remote Similarity NPD2801 Approved
0.6286 Remote Similarity NPD7411 Suspended
0.6262 Remote Similarity NPD6799 Approved
0.625 Remote Similarity NPD6980 Clinical (unspecified phase)
0.625 Remote Similarity NPD5403 Approved
0.6244 Remote Similarity NPD7768 Phase 2
0.6228 Remote Similarity NPD6312 Discontinued
0.622 Remote Similarity NPD2370 Clinical (unspecified phase)
0.6216 Remote Similarity NPD4419 Clinical (unspecified phase)
0.6211 Remote Similarity NPD3819 Phase 2
0.621 Remote Similarity NPD7799 Discontinued
0.6207 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6207 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6199 Remote Similarity NPD7959 Clinical (unspecified phase)
0.6193 Remote Similarity NPD7784 Clinical (unspecified phase)
0.6184 Remote Similarity NPD1511 Approved
0.6184 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6183 Remote Similarity NPD8404 Phase 2
0.6178 Remote Similarity NPD8434 Phase 2
0.6176 Remote Similarity NPD1549 Phase 2
0.6171 Remote Similarity NPD8014 Clinical (unspecified phase)
0.6164 Remote Similarity NPD7501 Clinical (unspecified phase)
0.6161 Remote Similarity NPD6599 Discontinued
0.6154 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6154 Remote Similarity NPD5401 Approved
0.6147 Remote Similarity NPD5242 Approved
0.6145 Remote Similarity NPD8067 Phase 3
0.614 Remote Similarity NPD7296 Approved
0.6135 Remote Similarity NPD5058 Phase 3
0.6127 Remote Similarity NPD7266 Discontinued
0.6124 Remote Similarity NPD1512 Approved
0.6121 Remote Similarity NPD8438 Clinical (unspecified phase)
0.6121 Remote Similarity NPD5353 Approved
0.6117 Remote Similarity NPD3750 Approved
0.6117 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6108 Remote Similarity NPD1510 Phase 2
0.61 Remote Similarity NPD8153 Approved
0.61 Remote Similarity NPD8152 Approved
0.6098 Remote Similarity NPD5619 Clinical (unspecified phase)
0.6089 Remote Similarity NPD8407 Phase 2
0.6077 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6066 Remote Similarity NPD1653 Approved
0.6055 Remote Similarity NPD8127 Discontinued
0.6048 Remote Similarity NPD1940 Clinical (unspecified phase)
0.6039 Remote Similarity NPD4628 Phase 3
0.6038 Remote Similarity NPD7458 Discontinued
0.6036 Remote Similarity NPD8470 Clinical (unspecified phase)
0.6032 Remote Similarity NPD7942 Clinical (unspecified phase)
0.6017 Remote Similarity NPD7497 Discontinued
0.6017 Remote Similarity NPD7827 Phase 1
0.6016 Remote Similarity NPD8366 Approved
0.601 Remote Similarity NPD3887 Approved
0.601 Remote Similarity NPD2354 Approved
0.6 Remote Similarity NPD2935 Discontinued
0.6 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6 Remote Similarity NPD2796 Approved
0.599 Remote Similarity NPD1240 Approved
0.5984 Remote Similarity NPD8491 Approved
0.598 Remote Similarity NPD4978 Clinical (unspecified phase)
0.597 Remote Similarity NPD6859 Clinical (unspecified phase)
0.5968 Remote Similarity NPD6625 Approved
0.5966 Remote Similarity NPD8090 Clinical (unspecified phase)
0.5965 Remote Similarity NPD3857 Clinical (unspecified phase)
0.5961 Remote Similarity NPD1899 Clinical (unspecified phase)
0.596 Remote Similarity NPD8469 Approved
0.5956 Remote Similarity NPD8368 Discontinued
0.5952 Remote Similarity NPD7390 Discontinued
0.5935 Remote Similarity NPD4972 Discontinued
0.5931 Remote Similarity NPD1607 Approved
0.5924 Remote Similarity NPD7004 Clinical (unspecified phase)
0.5922 Remote Similarity NPD1551 Phase 2
0.5921 Remote Similarity NPD6784 Approved
0.5921 Remote Similarity NPD6785 Approved
0.5915 Remote Similarity NPD7565 Approved
0.5913 Remote Similarity NPD8360 Approved
0.5913 Remote Similarity NPD8361 Approved
0.5906 Remote Similarity NPD6723 Discontinued
0.5899 Remote Similarity NPD2379 Clinical (unspecified phase)
0.589 Remote Similarity NPD4914 Approved
0.5888 Remote Similarity NPD3226 Approved
0.5887 Remote Similarity NPD3808 Clinical (unspecified phase)
0.5887 Remote Similarity NPD7907 Approved
0.5885 Remote Similarity NPD6398 Clinical (unspecified phase)
0.5882 Remote Similarity NPD230 Phase 1
0.5882 Remote Similarity NPD7229 Phase 3
0.588 Remote Similarity NPD6844 Discontinued
0.5875 Remote Similarity NPD6973 Clinical (unspecified phase)
0.5874 Remote Similarity NPD3748 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data